Polygenic Risk Scores: What Are They Good For?

      Matt was in many ways the stereotypical “all-American” teenager: a multisport athlete, class president, and valedictorian of his high school. It seemed preordained that he would attend his dream college and continue this extraordinary trajectory. But something went wrong. In his first year of college, he struggled academically and became increasing withdrawn. He sought treatment through the university’s health services. He was diagnosed with depression but engaged ambivalently with the clinic, with intermittent adherence with his medications and therapy appointments. His therapist worked hard to understand Matt’s resistance to treatment and to establish a therapeutic alliance. Matt ultimately disclosed—with a deep sense of shame—what he considered both his darkest secret and fear. When he was 6 years old, his father began behaving erratically, went missing for long periods of time; his father was committed against his will to a state psychiatric hospital, where he eventually died. Tearfully, Matt turns to you and asks, “What if the same thing is happening to me?”
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Jacobs P.
        • Brunton M.
        • Frackiewicz A.
        • Newton M.
        • Cook P.
        • Robson E.
        Studies on a family with three cytogenetic markers.
        Ann Hum Genet. 1970; 33: 325-336
        • Sullivan P.F.
        Questions about DISC1 as a genetic risk factor for schizophrenia.
        Mol Psychiatry. 2013; 18: 1050-1052
        • Henriksen M.G.
        • Nordgaard J.
        • Jansson L.B.
        Genetics of schizophrenia: Overview of methods, findings and limitations.
        Front Hum Neurosci. 2017; 11: 322
        • Purcell S.M.
        • Wray N.R.
        • Stone J.L.
        • Visscher P.M.
        • O’Donovan M.C.
        • Sullivan P.F.
        • et al.
        Common polygenic variation contributes to risk of schizophrenia and bipolar disorder.
        Nature. 2009; 460: 748-752
        • Schizophrenia Working Group of the Psychiatric Genomics Consortium
        Biological insights from 108 schizophrenia-associated genetic loci.
        Nature. 2014; 511: 421-427
        • Khera A.V.
        • Chaffin M.
        • Aragam K.
        • Emdin C.A.
        • Klarin D.
        • Haas M.
        • et al.
        Genome-wide polygenic score to identify a monogenic risk-equivalent for coronary disease.
        bioRxiv. 2017; ([published online ahead of print Nov 15])
        • Mavaddat N.
        • Pharoah P.D.P.
        • Michailidou K.
        • Tyrer J.
        • Brook M.N.
        • Bolla M.K.
        • et al.
        Prediction of breast cancer risk based on profiling with common genetic variants.
        J Natl Cancer Inst. 2015; 107: 1-15
        • Gandal M.J.
        • Haney J.R.
        • Parikshak N.N.
        • Leppa V.
        • Ramaswami G.
        • Hartl C.
        • et al.
        Shared molecular neuropathology across major psychiatric disorders parallels polygenic overlap.
        Science. 2018; 359: 693-697
        • Goodwin G.M.
        • Haddad P.M.
        • Ferrier I.N.
        • Aronson J.K.
        • Barnes T.R.H.
        • Cipriani A.
        • et al.
        Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology.
        J Psychopharmacol. 2016; 30: 495-553
        • Smoller J.W.
        • Craddock N.
        • Kendler K.
        • Lee P.H.
        • Neale B.M.
        • Nurnberger J.I.
        • et al.
        Identification of risk loci with shared effects on five major psychiatric disorders: A genome-wide analysis.
        Lancet. 2013; 381: 1371-1379